Editing liver tumours

@article{Colnot2013EditingLT,
  title={Editing liver tumours},
  author={S. Colnot and P. Fortes},
  journal={Gut},
  year={2013},
  volume={63},
  pages={709 - 710}
}
  • S. Colnot, P. Fortes
  • Published 2013
  • Biology, Medicine
  • Gut
    • There is an urgent need for new therapeutic options for hepatocellular carcinoma (HCC), which is currently the third cause of cancer-related death worldwide.1 HCC develops most frequently in the setting of cirrhosis. This premalignant condition occurs as a consequence of chronic liver disease, mainly as a result of hepatitis B and C viral infection, alcohol abuse and obesity. The poor efficacy of many antiproliferative agents against HCC is due in part to the inefficient drug delivery and… CONTINUE READING
    View on Publisher
    ncbi.nlm.nih.gov
    1 Citations
    One Citation
    Citation Type

    Citation Type

    Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.
    • 46

    References

    SHOWING 1-10 OF 11 REFERENCES
    Medical therapies for hepatocellular carcinoma: a critical view of the evidence
    • 249
    Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
    • 290
    Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
    • 964
    A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
    • 133
    • PDF
    MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
    • 112
    • PDF
    Altered adenosine-to-inosine RNA editing in human cancer.
    • 261
    • PDF
    A-to-I RNA editing: the "ADAR" side of human cancer.
    • 70
    Liver Disintegration in the Mouse Embryo Caused by Deficiency in the RNA-editing Enzyme ADAR1*
    • 341
    • PDF
    ADAR1 Forms a Complex with Dicer to Promote MicroRNA Processing and RNA-Induced Gene Silencing
    • 211
    • PDF
    Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2
    • 771
    • PDF